New York, NY -- (SBWIRE) -- 12/19/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: AK Steel Holding Corporation (NYSE:AKSN), Novavax, Inc (NASDAQ:NVAX), Opko Health Inc (NYSE:OPK), Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI)
AK Steel Holding Corporation (NYSE:AKSN) showed a volume of 6.39 million shares by the end of last trade whereas the average volume of the stock remained 6.00 million shares. The stock opened the session at $6.16 but then moved to $6.32. At that price, the stock showed a positive performance of 2.43%. AK Steel Holding Corporation (AK Holding) is an integrated producer of flat-rolled carbon, stainless and electrical steels and tubular products through its wholly-owned subsidiary, AK Steel Corporation (AK Steel and, together with AK Holding, the Company). The Company’s operations consist primarily of nine steelmaking and finishing plants and tubular production facilities located in Indiana, Kentucky, Ohio and Pennsylvania.
Will AKSN Continue To Move Higher? Find Out Here
Novavax, Inc (NASDAQ:NVAX) opened the session at $4.46 and closed the session at $4.51. The stock showed a positive performance of 0.89% in previous trading session. Traded with volume of 5.93 million shares in the prior session and the average volume of the stock remained 4.68 million shares. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional nanostructures, which incorporate immunologically important recombinant proteins. In July 2013, Novavax acquired approximately 97.4% of shares in Isconova AB.
For How Long NVAX will fight for Profitability? Read This Trend Analysis report
Opko Health Inc (NYSE:OPK) opened the session at $8.52 and closed the session at $8.86. The stock showed a positive performance of 5.48% in previous trading session. Traded with volume of 5.92 million shares in the prior session and the average volume of the stock remained 5.45 million shares. The beta of the stock remained 1.02. OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care tests, and pharmaceuticals and vaccines. Its lead program is a molecular diagnostics platform for the development and commercialization of blood-based tests for conditions. Its pharmaceutical segment consists of two operating segments: pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products, diagnostic tests and vaccines,
Why Should Investors Buy OPK After The Recent Gain? Just Go Here and Find Out
Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) the stock decreased -0.81% and finished the session at $8.24. Traded with volume of 5.66 million shares in the prior session and the average volume of the stock remained 758,920.00 shares. The beta of the stock remained 1.84. Spectrum Pharmaceuticals, Inc. (Spectrum) is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology. In the United States, the Company markets three oncology drugs, FUSILEV, FOLOTYN and ZEVALIN and also markets ZEVALIN outside of the United States, it has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of drug candidates.Apaziquone is studied in two Phase III clinical trials for non-muscle invasive bladder cancer,
Will SPPI Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)